Yamada, Y., Koizumi, W., Nishikawa, K., Gotoh, M., Fuse, N., Sugimoto, N., . . . Hyodo, I. (2019). Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer. Cancer science, 110(9), 2875-2883. https://doi.org/10.1111/cas.14117
Chicago Style (17th ed.) CitationYamada, Yasuhide, et al. "Sex Differences in the Safety of S‐1 Plus Oxaliplatin and S‐1 Plus Cisplatin for Patients with Metastatic Gastric Cancer." Cancer Science 110, no. 9 (2019): 2875-2883. https://doi.org/10.1111/cas.14117.
MLA (9th ed.) CitationYamada, Yasuhide, et al. "Sex Differences in the Safety of S‐1 Plus Oxaliplatin and S‐1 Plus Cisplatin for Patients with Metastatic Gastric Cancer." Cancer Science, vol. 110, no. 9, 2019, pp. 2875-2883, https://doi.org/10.1111/cas.14117.